Low carb and cancer screening
Each episode of Talk Evidence we take a dive into an issue or paper which is in the news, with a little help from some knowledgeable guests to help us to understand what it all means for clinical care, policy, or research.
In this episode:
Helen Macdonald take a deep dive into cancer screening tests, prompted by a paper in JAMA which showed most have no effect on all cause mortality, and news that the NHS is evaluating a single test which screens for 50 common cancers - we ask Barry Kramer, former director of the Division of Cancer Prevention, at the U.S. National Cancer Institute to help explain how to hold those two...
Source: The BMJ Podcast - November 6, 2023 Category: General Medicine Authors: BMJ Group Source Type: podcasts
What are the benefits and risks of methylxanthines (mild stimulant medicines) for premature babies whose breathing pauses during sleep (apnea)?
An important problem for babies who are born too early is a condition called apnea and a new Cochrane review published in October 2023 brings together the evidence on the effects of a class of drugs called methylxanthines. We asked one of the authors, Matteo Bruschettini from Cochrane Sweden, to tell us about the review ' s findings in this podcast and he used an AI voice from elevenlabs.io to make the recording. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - November 3, 2023 Category: General Medicine Authors: Cochrane Source Type: podcasts
Thermal stability and storage of human insulin
The many Cochrane Reviews related to the use of insulin for people with diabetes were added to in November 2023 with a new review of the thermal stability and storage of human insulin. Here ' s Bernd Richter, lead author and Emeritus Coordinating Editor of the Cochrane Metabolic and Endocrine Disorders Group, based in D üsseldorf, Germany, to tell us what they found. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - November 2, 2023 Category: General Medicine Authors: Cochrane Source Type: podcasts
JAMA Internal Medicine : Nurse Care Management for Opioid Use Disorder Treatment
Interview with Katharine A. Bradley, MD, MPH, author of Nurse Care Management for Opioid Use Disorder Treatment: The PROUD Cluster Randomized Clinical Trial, and Michael A. Incze, MD, MSEd, and Deborah S. Finnell, PhD, RN, authors of Amplifying the Strength and Leadership of Nurses in Opioid Use Disorder Care—Loud and PROUD. Hosted by Louise Aronson, MD, MFA. Related Content: Nurse Care Management for Opioid Use Disorder Treatment Amplifying the Strength and Leadership of Nurses in Opioid Use Disorder Care—Loud and PROUD (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - October 30, 2023 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
JAMA Neurology : Atrial Fibrillation In Patients With Stroke Attributed to Large- or Small-Vessel Disease
Interview with Richard A. Bernstein, MD, PhD, author of Atrial Fibrillation in Patients With Stroke Attributed to Large- or Small-Vessel Disease: 3-Year Results From the STROKE AF Randomized Clinical Trial. Hosted by Cynthia E. Armand, MD. Related Content: Atrial Fibrillation In Patients With Stroke Attributed to Large- or Small-Vessel Disease (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - October 30, 2023 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
The effect of individual-level interventions for reducing stress in healthcare workers
Cochrane Work has produced many systematic reviews of interventions that might help workers stay safe in the workplace. In this podcast, Roos Schelvis, senior researcher in mental health and work and Sietske Tamminga, assistant professor, both from Amsterdam University Medical Center in the Netherlands discuss the May 2023 update of one of these, which looks at the effects of individual-level stress interventions for healthcare workers. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - October 30, 2023 Category: General Medicine Authors: Cochrane Source Type: podcasts
JAMA Ophthalmology : Risk of Stroke, Myocardial Infarction, and Death After Retinal Artery Occlusion
Interview with Prithvi Mruthyunjaya, MD, MHS, author of Risk of Stroke, Myocardial Infarction, and Death After Retinal Artery Occlusion. Hosted by Neil M. Bressler, MD. Related Content: Risk of Stroke, Myocardial Infarction, and Death After Retinal Artery Occlusion (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - October 26, 2023 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
JAMA Psychiatry : Treatment Outcomes With Licensed and Unlicensed Stimulant Doses for Adults With ADHD
Interview with Michael H. Bloch, MD, MS, and Samuele Cortese, MD, PhD, authors of Treatment Outcomes With Licensed and Unlicensed Stimulant Doses for Adults With Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis. Hosted by John Torous, MD, MBI. Related Content: Treatment Outcomes With Licensed and Unlicensed Stimulant Doses for Adults With Attention-Deficit/Hyperactivity Disorder (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - October 25, 2023 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
JAMA Dermatology : Patient Perspectives on Social Risk Screening and Documentation
Interview with Aileen Y. Chang, MD, author of Patient Perspectives on Social Risk Screening and Documentation in a Dermatology Clinic. Hosted by Adewole S. Adamson, MD, MPP. Related Content: Patient Perspectives on Social Risk Screening and Documentation in a Dermatology Clinic (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - October 25, 2023 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
JAMA Cardiology : Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction
Interview with Divaka Perera, MA, MD, author of Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction: A Prespecified Secondary Analysis of the REVIVED-BCIS2 Trial, and Julio A. Panza, MD, author of Assessment of Myocardial Viability in Ischemic Cardiomyopathy—Scarred by the Data but Still Alive. Hosted by James E. Udelson, MD. Related Content: Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction Assessment of Myocardial Viability in Ischemic Cardiomyopathy—Scarred by the Data but Still Alive (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - October 25, 2023 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
Traditional Chinese Medicine Meets Evidence-Based Medicine in the Acutely Infarcted Heart
JAMA Executive Editor Gregory Curfman, MD, speaks with Richard G. Bach, MD, professor of medicine and medical director of the cardiac intensive care unit at the Washington University School of Medicine in St. Louis, about the use of traditional Chinese medicine to treat patients with acute ST-segment elevation myocardial infarction. Related Content: Traditional Chinese Medicine Meets Evidence-Based Medicine in the Acutely Infarcted Heart (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - October 24, 2023 Category: General Medicine Authors: JAMA Network Source Type: podcasts
Traditional Chinese Medicine for STEMI, Early Metformin for Gestational Diabetes, Review of Knee Pain, and more
Editor’s Summary by Karen E. Lasser, MD, MPH, Senior Editor of JAMA, the Journal of the American Medical Association, for the October 24/31, 2023, issue. Related Content: Audio Highlights (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - October 24, 2023 Category: General Medicine Authors: JAMA Network Source Type: podcasts
JAMA Surgery : Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in DCIS
Interview with Seema A. Khan, MD, author of Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women With Ductal Carcinoma In Situ: A Randomized Clinical Trial. Hosted by Amalia Cochran, MD. Related Content: Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women With Ductal Carcinoma In Situ (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - October 23, 2023 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
How can we communicate better with people and communities about measures which help to prevent and control COVID-19?
Clear communication with the public is a key part of the response to disasters and health emergencies, and the October 2023 update of a rapid review from 2020 investigates this in relation to measures to help to prevent and control COVID-19. Here ' s lead author Rebecca Ryan from La Trobe University in Australia to tell us more. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - October 23, 2023 Category: General Medicine Authors: Cochrane Source Type: podcasts
Is methylphenidate an effective treatment for children and adolescents with attention deficit hyperactivity disorder (ADHD) and does it cause unwanted effects?
The Cochrane Developmental, Psychosocial and Learning Problems Group produced several reviews relevant to the treatment of attention deficit hyperactivity disorder and the update for one of these, investigating the drug methylphenidate, was published in March 2023. Here ' s one of the authors, Maja Storm from the Psychiatric Research Unit, Region Zealand in Denmark, to tell us about the latest evidence. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - October 23, 2023 Category: General Medicine Authors: Cochrane Source Type: podcasts
